Patents by Inventor Alexandre Calon

Alexandre Calon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL CULTURE SYSTEM AND CELL CULTURE METHOD
    Publication number: 20260201294
    Abstract: A cell culture system (1) comprising a body of the device (2) separating a first zone (3) and a second zone (4) and comprising at least one microchannel (5) fluidly communicating the first zone (3) with the second zone (4). A cell culture plate or a well plate (18) comprising at least one cell culture system (1). and a method for cell culturing using the cell culture system (1), comprising seeding a first cell type in the first zone (3) and seeding a second cell type on top of the first cell type. This method may further comprise the application of a treatment in the second zone (4) so that it passes to the first zone (3) through the at least one microchannel (5).
    Type: Application
    Filed: November 23, 2023
    Publication date: July 16, 2026
    Inventors: Anna LABERNADIE, Xavier TREPAT GUIXER, Alexandre CALON
  • METHODS AND KITS FOR THE PROGNOSIS OF COLORECTAL CANCER
    Publication number: 20150289795
    Abstract: The invention relates to methods for predicting the risk of relapse of cancer patients as well as methods for providing personalized medicine to said patients based on the expression levels of different genes the expression of which is induced in response to TGF-beta stimulation. The invention also relates to kits for carrying out the diagnostic and predictive medicine methods.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 15, 2015
    Inventors: Eduard Batlle Gómez, Elena Sancho Suils, David Rossell Ribera, Alexandre Calon, Elisa Espinet Hernández, Sergio Palomo Ponce
  • METHODS AND KITS FOR THE PROGNOSIS OF COLORECTAL CANCER
    Publication number: 20140314662
    Abstract: The invention relates to methods for predicting the risk of relapse of cancer patients as well as methods for providing personalized medicine to said patients based on the expression levels of different genes the expression of which is induced in response to TGF-beta stimulation. The invention also relates to kits for carrying out the diagnostic and predictive medicine methods.
    Type: Application
    Filed: November 12, 2012
    Publication date: October 23, 2014
    Inventors: Eduard Batlle-Gomez, Elena Sancho Suils, David Rossell Ribera, Alexandre Calon, Elisa Espinet Hernandez, Sergio Palomo Ponce